$HBAN

Wells Fargo Adjusts Price Target on Huntington Bancshares to $19 From $21

Wells Fargo lowered its price target for Huntington Bancshares from $21 to $19. The stock closed at $15.66 on the Nasdaq, reflecting a 0.38% decrease over five days and a 9.74% decline year-to-date. The adjustment is based on a weighted average of various ratings, including valuation and EPS revisions.

Original reporting
Published Oct 23, 2026, 10:46 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 23, 2026, 10:58 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefFinancial news
Primary signal
$HBAN
Bearish
medium confidence
Mentioned
$HBAN
Relevance
5/10
AlphAI data visualization · based on marketscreener.com
Decision brief

The 30-second read

$HBANBearishLow
01

Why it matters

The downgrade may prompt short-term selling pressure, but broader market factors will dominate.

02

Market read

Analyst target changes can influence trader sentiment, especially for mid-cap regional banks.

03

What to watch

No mention of recent earnings or balance sheet changes that might justify the downgrade.

Relevance 5/10Novelty 5/10Timing: pre-market today

Background

Wells Fargo's analyst team adjusted its valuation model for Huntington Bancshares, reflecting a lower expected future performance.

Company-level read

Ticker impact

$HBANBearishMedium confidence
Context

Wells Fargo lowered its price target for Huntington Bancshares to $19 from $21, indicating a revised valuation outlook.

Expected impact

likely pressure as the market prices in the lower target

Evidence & confidence

Analyst target reductions often precede short-term price declines, especially when no other catalyst is present.

Market effects

May signal a more cautious stance on regional banks.

Potential modest impact on U.S. banking sector sentiment.

Limited to U.S. financial markets.

Counterpoint

The target cut could be overly pessimistic if HBAN's fundamentals remain strong.

Key entities

  • Wells Fargo

    Issuer of the revised price target.

  • Huntington Bancshares

    Subject of the price target adjustment.

Related articles

$HBANMedAI 8/10

Huntington Bancshares 3Q 2026: Revenue $2.79B, EPS $0.33— 10-Q Summary

Huntington Bancshares reported 3Q 2026 revenue of $2.79B, up 30.8% YoY, and net income of $721M, up 14.6% YoY. EPS was $0.33, down 19.5% YoY, due to acquisition-related expenses. Growth was driven by acquisitions, organic growth, and higher net interest income. Management highlighted progress in integrating recent acquisitions and investing in technology.

$SEBMed

Sweden’s SEB pauses buybacks as Barclays plans further capital returns ahead of Basel 3.1

SEB paused buybacks due to capital buffer pressure from model adjustments and loan growth, reporting a 17.1% CET1 ratio. Barclays announced a GBP 500M buyback, expecting Basel 3.1 to reduce its CET1 ratio but maintain distribution headroom. EU agreed lower capital requirements for qualifying securitisations. Huntington Bancshares saw diverging capital ratios due to interest-rate losses. BPI's provisions fell despite worsening problem-loan metrics.

$HBANMedAI 8/10

Huntington Bancshares Inc (HBAN) (Q3 2026) Earnings Call Highlights: Strong Fee Growth

Huntington Bancshares (HBAN) reported strong Q3 2026 results, with fee revenue up over 15% YoY and commercial loan growth driving a 1.1% increase in loan balances. The company expects 2027 EPS growth of over 20% and ROTCE of 17%-18%. However, it faces challenges like a competitive environment and slightly lowered fee revenue guidance for Q4. The bank repurchased $460 million in stock YTD and plans $1.8-$1.9 billion in buybacks for 2026-2027.

$HBANHighAI 8/10

Huntington Bancshares Inc (HBAN) (Q3 2026) Earnings Call Highlig

Huntington Bancshares (HBAN) reported Q3 2026 earnings with net interest income up 0.9% quarter-over-quarter and 37% year-over-year. Net interest margin increased 4 basis points to 3.25%. Non-interest expense remained flat, while value-added fee revenue rose over 15% year-over-year. Loans grew 1.1% period-end, and deposits increased 0.2%. The company expects 2027 EPS growth of over 20% and plans $1.8-$1.9 billion in share repurchases through 2027.

$HBANMed

Huntington (HBAN) Q3 2026 Earnings Call Transcript

Huntington (HBAN) reported strong Q3 2026 earnings, with C&I growth driven by national commercial strategy. The company expects 2027 EPS to grow over 20% from 2025, with ROTCE in the 17-18% range. They have completed $460 million in share repurchases year-to-date and plan to return substantial capital to shareholders. Huntington's operating model combines local and national commercial banking, with $191 billion in loans and $225 billion in deposits.

$HBANMed

What Huntington Bancshares (HBAN) Said on Its Q3 Earnings Call

Huntington Bancshares (HBAN) reported Q3 earnings with net interest income at $2.1B, up 0.9% sequentially. Net interest margin increased to 3.25%, with management expecting it to remain flat in Q4. Fee revenue grew 15% YoY, and noninterest expense was stable. The company repurchased $460M of common stock YTD and expects $1.8B-$1.9B in repurchases over 2023-2024. Net charge-offs were 31 basis points, with stable credit performance.